Cancer can push white blood cell counts in either direction. Some cancers drive counts well above normal, while others, particularly blood cancers that crowd out healthy bone marrow, drop them dangerously low. Chemotherapy and other cancer treatments add another layer, frequently causing temporary but significant drops. The normal white blood cell (WBC) range is 4,500 to 11,000 cells per microliter of blood, and cancer can move that number in both directions, sometimes dramatically.
When Cancer Raises White Blood Cell Counts
A high WBC count is common in several cancer scenarios. Leukemias, particularly chronic myelogenous leukemia, involve the uncontrolled production of abnormal white blood cells in the bone marrow. People with chronic lymphocytic leukemia (CLL) often have very high counts due to an excess of lymphocytes, though these abnormal cells don’t fight infection the way healthy white blood cells do. In extreme cases, counts can climb to 100,000 cells per microliter or higher, a condition called hyperleukocytosis that requires urgent evaluation.
Solid tumors can also raise WBC counts, even when the cancer has nothing to do with the blood or bone marrow. Lung, ovarian, kidney, colon, and stomach cancers are among those that release signaling molecules that stimulate white blood cell production. This is called a paraneoplastic reaction: the tumor essentially tricks the bone marrow into overproducing cells. In one documented case of aggressive thyroid cancer, the tumor secreted high levels of an inflammatory signaling molecule called IL-6, causing severe elevation in white blood cells that initially looked like an infection.
Cancer that has spread to the bone marrow can also trigger elevated counts by disrupting normal blood cell production at the source.
When Cancer Lowers White Blood Cell Counts
Blood cancers like leukemia, lymphoma, and multiple myeloma can suppress normal white blood cell production by crowding the bone marrow with abnormal cells. Even though the total WBC count might appear high in leukemia due to malignant cells, the number of functional, infection-fighting white blood cells is often low. This creates a paradox: the blood test looks high, but the immune system is weakened.
The more common reason cancer patients experience low WBC counts, though, is treatment. Chemotherapy, targeted drug therapy, radiation, and bone marrow transplants all damage the rapidly dividing cells in bone marrow that produce white blood cells. After a round of chemotherapy, white blood cell counts typically bottom out around day 7, a point called the nadir. From there, the marrow gradually recovers, but the window of vulnerability is real and significant.
Which Types of White Blood Cells Change
A standard blood test doesn’t just measure total WBC count. It also breaks down the different types, and the specific pattern matters. Neutrophils, the most common type and the body’s first responders against bacterial infection, are frequently elevated in solid tumor cancers and chronic myelogenous leukemia. A rise in lymphocytes points more toward chronic lymphocytic leukemia. Elevated eosinophils can appear in Hodgkin’s disease. Basophils may rise in certain myeloproliferative disorders.
These patterns help doctors distinguish between a WBC count that’s high from an infection versus one that signals cancer. A count of 15,000 from a bad case of pneumonia looks very different under the microscope than a count of 15,000 driven by leukemia cells.
Symptoms of Abnormal Counts
High white blood cell counts from cancer don’t always produce obvious symptoms on their own. When they do, the signs tend to overlap with general cancer symptoms: fatigue, weakness, weight loss, fever, night sweats, and swollen lymph nodes that feel like lumps under the skin in the neck, armpits, or groin. An enlarged spleen can cause fullness or pain in the upper left abdomen, sometimes making you feel full after eating very little.
Low white blood cell counts are more dangerous in an immediate, practical sense. The primary risk is infection, and without enough functional white blood cells, even minor bacteria your body would normally handle can become serious. A fever above 100.4°F that lasts at least an hour in someone with very low neutrophil counts (below 1,500 cells per microliter) is called neutropenic fever and is treated as a medical emergency. Severe neutropenia, with counts below 500, puts you at high risk. Below 100, the risk is profound.
How Low Counts Are Managed During Treatment
Because chemotherapy predictably drops white blood cell counts, oncology teams monitor bloodwork closely throughout treatment cycles. When counts fall too low or stay down too long, doctors can prescribe medications that stimulate the bone marrow to produce white blood cells faster. These growth factor injections shorten the window of vulnerability and reduce infection risk. They’re commonly given to patients receiving chemotherapy regimens known to cause significant drops.
During the nadir period after chemotherapy, you may be advised to avoid crowds, wash hands frequently, and watch carefully for any signs of infection. Even a low-grade fever during this window warrants a call to your oncology team, because your body may not be able to mount its usual immune response.
What an Abnormal WBC Count Means on Its Own
An abnormal white blood cell count on a routine blood test does not automatically mean cancer. Infections, allergies, autoimmune conditions, stress, and even vigorous exercise can shift counts outside the normal range. The vast majority of elevated WBC results trace back to infections or inflammation, not malignancy. Similarly, certain medications, viral infections, and autoimmune diseases can lower counts without any cancer being present.
What raises concern is the degree of abnormality and the pattern. A count approaching 100,000 cells per microliter with no obvious infection strongly suggests leukemia or a myeloproliferative disorder. Persistent, unexplained elevation or depression of specific cell types, especially when paired with symptoms like unexplained weight loss, night sweats, or easy bruising, prompts further investigation with bone marrow biopsy or imaging. A single slightly elevated or slightly low result, in isolation, is rarely the whole story.